First Tracks Biotherapeutics annual free cash flow
2023
2024
First Tracks Biotherapeutics Free Cash Flow (FCF) History (TRAX)
First Tracks Biotherapeutics reported −$126.2M in free cash flow for fiscal 2024, a decrease of $32.4M from the previous fiscal year.
View full First Tracks Biotherapeutics company overviewFirst Tracks Biotherapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$126.2M | −$32.4M | — | — |
| 2023 | 2023-12-31 | −$93.8M | — | — | — |
First Tracks Biotherapeutics quarterly free cash flow
Q1.26
Q2.26
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | 2026-06-30 | −$31.9M | $6.7M | — | — |
| Q1 2026 · Mar 31 | 2026-03-31 | −$32.6M | $12.5M | — | — |
| Q2 2026 · Jun 30 | 2025-06-30 | −$38.7M | — | — | — |
| Q1 2026 · Mar 31 | 2025-03-31 | −$45.0M | — | — | — |
First Tracks Biotherapeutics free cash flow growth trends
First Tracks Biotherapeutics's latest reported quarter, Q2 2026 · Jun 30, generated −$31.9M in free cash flow, an increase of $6.7M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review First Tracks Biotherapeutics source filings ↗